The changing reality of urothelial bladder cancer: should non‐squamous variant histology be managed as a distinct clinical entity?

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-410x|116|2|236-240

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.116, Iss.2, 2015-08, pp. : 236-240

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erlotinib versus Pemetrexed for Pretreated Non-Squamous Non-Small Cell Lung Cancer Patients in Clinical Practice

By  

Oncology, Vol. 84, Iss. 5, 2013-02 ,pp. : 255-264

Karger

Access to resources Recommend Favorite

An Unusual Variant of Bladder Carcinoma: Microcystic Urothelial Carcinoma

By  

Current Urology, Vol. 1, Iss. 3, 2008-03 ,pp. : 166-168

Karger

Access to resources Recommend Favorite

Metastatic Urothelial Carcinoma of the Prepuce and Glans Penis: Suspected Implantation of Non-Muscle-Invasive Bladder Cancer via Urine

By  

Case Reports in Oncology, Vol. 7, Iss. 2, 2014-07 ,pp. : 509-512

Karger

Access to resources Recommend Favorite

Neutrophilic dermatosis of the dorsal hands: a localized variant of Sweet's syndrome or a distinct entity?

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 2, 2015-02 ,pp. : e66-e67

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bevacizumab in the Treatment of Advanced, Non-Squamous Non-Small Cell Lung Cancer: An Evidence-Based Approach

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 350-358

Karger

Access to resources Recommend Favorite